Scholars Central

Case reportPublished 29 Feb 2024

Immunotherapy in Omental Cancer: Emerging Treatments and Clinical Trials

Authors: Ishag Adam

Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, United States

Insights in Gynecologic Oncology

Volume 9 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Omentum cancer, also known as omental cancer, refers to cancer that originates in the omentum, a fold of the peritoneum (the membrane lining the abdominal cavity) that hangs down from the stomach and covers the intestines. The omentum contains fat and is rich in blood vessels, lymphatics, and immune cells. Omentum cancer can either be primary, meaning it starts in the omentum itself, or secondary (metastatic), meaning it spreads to the omentum from another primary cancer site, such as the ovaries, colon, stomach, or pancreas. Symptoms of omentum cancer may include abdominal pain, bloating, nausea, vomiting, weight loss, and changes in bowel habits. Treatment typically involves a combination of surgery, chemotherapy, and radiation therapy, depending on the type and stage of the cancer. Early detection and treatment can improve outcomes for individuals with omentum cancer

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Insights in Gynecologic Oncology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInsights in Gynecologic Oncology
  • SubjectOncology & Cancer
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Ishag Adam”